Press Release No. 54
Berlin
The signatures of peritoneal metastases
New biomarkers could predict which therapy is likely to be most effective in treating the distant metastases of colorectal cancer. Researchers from the MDC and Charité as well as from industry partners have identified the molecular signatures of such metastases using mouse and 3D models, as they now report in the journal “Molecular Cancer”.